These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 20521907)
21. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization. Goyanes A; Souto C; Martínez-Pacheco R Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024 [TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of mefenamic acid sustained release matrix pellets. Ibrahim MA Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315 [TBL] [Abstract][Full Text] [Related]
23. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy. Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519 [TBL] [Abstract][Full Text] [Related]
24. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose. Charoenthai N; Kleinebudde P; Puttipipatkhachorn S AAPS PharmSciTech; 2007 Aug; 8(3):E64. PubMed ID: 17915814 [TBL] [Abstract][Full Text] [Related]
25. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug. Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003 [TBL] [Abstract][Full Text] [Related]
26. Self-emulsifying Pellets Prepared by Extrusion/Spheronization: In vitro/In vivo Evaluation. Rahman MA; Mujahid M; Hussain A Recent Pat Drug Deliv Formul; 2016; 10(3):245-252. PubMed ID: 27774911 [TBL] [Abstract][Full Text] [Related]
27. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Abdalla A; Klein S; Mäder K Eur J Pharm Sci; 2008 Dec; 35(5):457-64. PubMed ID: 18940249 [TBL] [Abstract][Full Text] [Related]
28. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Mallipeddi R; Saripella KK; Neau SH Int J Pharm; 2010 Jan; 385(1-2):53-65. PubMed ID: 19853027 [TBL] [Abstract][Full Text] [Related]
29. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Serratoni M; Newton M; Booth S; Clarke A Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237 [TBL] [Abstract][Full Text] [Related]
31. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization. Goyanes A; Souto C; Martínez-Pacheco R Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853 [TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process. Karim S; Baie SH; Hay YK; Bukhari NI Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797 [TBL] [Abstract][Full Text] [Related]
33. The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization. Podczeck F; Maghetti A; Newton JM Eur J Pharm Sci; 2009 Jun; 37(3-4):334-40. PubMed ID: 19491024 [TBL] [Abstract][Full Text] [Related]
34. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization. Podczeck F; Knight PE; Newton JM Int J Pharm; 2008 Feb; 350(1-2):145-54. PubMed ID: 17905548 [TBL] [Abstract][Full Text] [Related]
35. Production and characterization of pellets using Avicel CL611 as spheronization aid. Puah SY; Yap HN; Chaw CS Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532 [TBL] [Abstract][Full Text] [Related]
36. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation. Afrasiabi Garekani H; Aftabi SF; Nia FF; Javidi M; Nokhodchi A; Sadeghi F Pharm Dev Technol; 2019 Jul; 24(6):720-728. PubMed ID: 30776937 [TBL] [Abstract][Full Text] [Related]
37. Extrusion-spheronisation of microcrystalline cellulose pastes using a non-aqueous liquid binder. Mascia S; Seiler C; Fitzpatrick S; Wilson DI Int J Pharm; 2010 Apr; 389(1-2):1-9. PubMed ID: 20123008 [TBL] [Abstract][Full Text] [Related]
38. Influence of the type of cellulose on properties of multi-unit target releasing in stomach dosage form with verapamil hydrochloride. Sawicki W; Łunio R; Walentynowicz O; Kubasik-Juraniec J Acta Pol Pharm; 2007; 64(1):81-8. PubMed ID: 17665855 [TBL] [Abstract][Full Text] [Related]
39. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts. Sriamornsak P; Nunthanid J; Luangtana-anan M; Weerapol Y; Puttipipatkhachorn S Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003 [TBL] [Abstract][Full Text] [Related]
40. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization. Boutell S; Newton JM; Bloor JR; Hayes G Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]